Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Bevacizumab Subconjunctival Injections on Corneal Newvessels

NCT01501760 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT01501760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01501760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Bevacizumab Subconjunctival Injections on Corneal Newvessels
Lead sponsor
University Hospital, Limoges
Phase
Phase 3
Overall status
Completed
Start date
May 13, 2012
Completion date
October 31, 2019
Enrollment
38 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

corneal newvessels